Royalty Pharma Appoints Greg Raskin to Lead Academic Partnerships
Royalty Pharma plc (Nasdaq: RPRX) has appointed Greg Raskin, M.D., as Senior Vice President, Head of Academic Initiatives, effective August... Read More
The post Royalty Pharma Appoints Greg Raskin to Lead Academic Partnerships appeared first on citybiz.